Healthy Extracts (HYEX) Change in Accured Expenses (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Change in Accured Expenses came in at -$4211.0 in Q4 2025, down 107.28% year-on-year from $57861.0 in Q4 2024, and down 3151.45% quarter-over-quarter from $138.0 in Q3 2025.
Healthy Extracts (HYEX) Change in Accured Expenses (2015 - 2025) Analysis & Trends
Healthy Extracts' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$4211.0 for Q4 2025.
- On a quarterly basis, Change in Accured Expenses fell 107.28% year-over-year to -$4211.0 in Q4 2025; TTM through Dec 2025 was $2999.0, a 90.15% decrease from a year earlier, with the FY2025 full-year figure at $2999.0, down 90.15% from the prior year.
- Change in Accured Expenses retreated to -$4211.0 in Q4 2025 per HYEX's latest filing, from $138.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $97372.0 in Q3 2023 and bottomed at -$83519.0 in Q2 2023.
- The 5-year median for Change in Accured Expenses is $1049.0 (2021), against an average of $8794.6.
- Across the five-year window, Change in Accured Expenses soared 1387.37% in 2021 and sank 878.01% in 2023, its largest moves.
- Year by year, Change in Accured Expenses stood at -$13850.0 in 2021, then surged by 538.03% to $60667.0 in 2022, then jumped by 46.75% to $89026.0 in 2023, then sank by 35.01% to $57861.0 in 2024, then plunged by 107.28% to -$4211.0 in 2025.
- Per Business Quant, the three latest HYEX Change in Accured Expenses figures stand at -$4211.0 (Q4 2025), $138.0 (Q3 2025), and $735.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -12.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | -4,211.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4,211.00 |
| Dec 31, 2025 | -4,211.00 |
| Sep 30, 2025 | 138.00 |
| Sep 30, 2025 | 138.00 |
| Jun 30, 2025 | 735.00 |
| Jun 30, 2025 | 735.00 |
| Mar 31, 2025 | 6,337.00 |
| Mar 31, 2025 | 6,337.00 |
| Dec 31, 2024 | 57,861.00 |
| Dec 31, 2024 | 57,861.00 |
| Sep 30, 2024 | -944.00 |
| Sep 30, 2024 | -944.00 |
| Jun 30, 2024 | -12,737.00 |
| Jun 30, 2024 | -12,737.00 |
| Mar 31, 2024 | -13,739.00 |
| Mar 31, 2024 | -13,739.00 |
| Dec 31, 2023 | 89,026.00 |
| Dec 31, 2023 | 89,026.00 |
| Sep 30, 2023 | 97,372.00 |
| Sep 30, 2023 | 97,372.00 |